These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24004669)

  • 21. MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic large cell lymphoma.
    Sinatkas V; Stathopoulou K; Xagoraris I; Ye J; Vyrla D; Atsaves V; Leventaki V; Medeiros LJ; Rassidakis GZ; Drakos E
    Leuk Lymphoma; 2021 Jul; 62(7):1563-1573. PubMed ID: 33569988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult.
    Wang CX; Wang H; Li J; Ma HH; Yu B; Shi SS; Zhou XJ; Shi QL
    Int J Clin Exp Pathol; 2014; 7(3):1182-7. PubMed ID: 24696735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis.
    Martinengo C; Poggio T; Menotti M; Scalzo MS; Mastini C; Ambrogio C; Pellegrino E; Riera L; Piva R; Ribatti D; Pastorino F; Perri P; Ponzoni M; Wang Q; Voena C; Chiarle R
    Cancer Res; 2014 Nov; 74(21):6094-106. PubMed ID: 25193384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Detection of chromosomal translocations involving ALK gene in anaplastic large cell lymphoma by fluorescence in-situ hybridization and its clinical significance].
    Huang WT; Li XQ; Yao XH; Lu YM; Sheng WQ; Lu HF; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):371-5. PubMed ID: 22932403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anaplastic lymphoma kinase gene abnormality and the expression of its fusion protein in primary systemic anaplastic large cell lymphoma].
    Shi YF; Liu CL; Zhou CJ; Gong LP; Dong LN; Li M; Huang X; Gao ZF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):380-6. PubMed ID: 18677384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8 expression in anaplastic large cell lymphoma correlates with noncommon morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative anaplastic large cell lymphoma.
    Shen J; Medeiros LJ; Li S; Wang SA; Lin P; Khanlari M; Iyer SP; Yin CC; Tang G; Jorgensen JL; Hu S; Miranda RN; Xu J
    Hum Pathol; 2020 Apr; 98():1-9. PubMed ID: 32032618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
    Shi Y; Chen G; Zhou XG; Gong LP; Yu R; Zheng YY; Xie JL; Jin Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):235-9. PubMed ID: 20654121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children.
    Gualco G; Chioato L; Weiss LM; Harrington WJ; Bacchi CE
    Am J Clin Pathol; 2009 Jul; 132(1):28-33. PubMed ID: 19864230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaplastic large cell lymphoma, ALK-positive.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression.
    Desjobert C; Renalier MH; Bergalet J; Dejean E; Joseph N; Kruczynski A; Soulier J; Espinos E; Meggetto F; Cavaillé J; Delsol G; Lamant L
    Blood; 2011 Jun; 117(24):6627-37. PubMed ID: 21471522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biology and management of systemic anaplastic large cell lymphoma.
    Hapgood G; Savage KJ
    Blood; 2015 Jul; 126(1):17-25. PubMed ID: 25869285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma.
    Rassidakis GZ; Thomaides A; Wang S; Jiang Y; Fourtouna A; Lai R; Medeiros LJ
    Leukemia; 2005 Sep; 19(9):1663-9. PubMed ID: 15990866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects.
    Tsuyama N; Sakamoto K; Sakata S; Dobashi A; Takeuchi K
    J Clin Exp Hematop; 2017; 57(3):120-142. PubMed ID: 29279550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaplastic Large Cell Lymphoma: Contemporary Concepts and Optimal Management.
    Shustov A; Soma L
    Cancer Treat Res; 2019; 176():127-144. PubMed ID: 30596216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
    Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
    Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.
    Agrawal K; Shet T; Sridhar E; Dhende S; Sengar M; Arora B; Laskar S; Gujral S; Menon H; Banavali S
    Indian J Pathol Microbiol; 2017; 60(4):533-540. PubMed ID: 29323068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Long Non-Coding RNA MIR503HG Enhances Proliferation of Human ALK-Negative Anaplastic Large-Cell Lymphoma.
    Huang PS; Chung IH; Lin YH; Lin TK; Chen WJ; Lin KH
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29758012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variant translocation partners of the anaplastic lymphoma kinase (ALK) gene in two cases of anaplastic large cell lymphoma, identified by inverse cDNA polymerase chain reaction.
    Takeoka K; Okumura A; Honjo G; Ohno H
    J Clin Exp Hematop; 2014; 54(3):225-35. PubMed ID: 25501114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma.
    Wu C; Molavi O; Zhang H; Gupta N; Alshareef A; Bone KM; Gopal K; Wu F; Lewis JT; Douglas DN; Kneteman NM; Lai R
    Blood; 2015 Jul; 126(3):336-45. PubMed ID: 25921060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
    Oregel KZ; Everett E; Zhang X; Nagaraj G
    Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.